Regeneron Pharmaceuticals shares owned by Byrne Asset Management
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Byrne Asset Management
from 13F filings
Historical chart of Byrne Asset Management investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Byrne Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Byrne Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $43k | 41 | 1050.85 |
| 2024-03-31 | $40k | 41 | 962.49 |
| 2023-12-31 | $36k | 41 | 874.37 |
| 2023-09-30 | $34k | 41 | 829.27 |
| 2023-06-30 | $29k | 41 | 707.32 |
| 2023-03-31 | $34k | 41 | 829.27 |
| 2022-12-31 | $30k | 41 | 721.49 |
| 2022-09-30 | $33k | 48 | 687.50 |
| 2022-06-30 | $28k | 48 | 583.33 |
| 2022-03-31 | $34k | 48 | 708.33 |
| 2021-12-31 | $34k | 54 | 629.63 |